Teekay Tankers Ltd. provides marine transportation services to oil industries in Bermuda and internationally. The company offers voyage and time charter services; offshore ship-to-ship transfer of ...

THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase), a thrombolytic or clot ...

When the puck drops this Sunday at CHaD’s Battle of the Badges Hockey Championship ... feature is pairing up the skaters with “Little Buddies,” children who have been or are being treated ...

Col. Jerry Drew has become the first instructor at the Command and General Staff College to receive the Master Army Instructor Badge. This achievement will be shared by only 178 other instructors ...

Doctors usually prescribe a starting dose and a maintenance dose. Ozempic’s typical starting dosage is 0.25 milligrams (mg) once per week for 4 weeks. Then your doctor will increase your dose to ...

There is interest in using quercetin for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful. Pregnancy and breast-feeding: There isn't ...

Also, follow the dosage instructions on the label carefully. Like other single amino acids, it’s recommended to take L-arginine between meals for maximum absorption. L-arginine supplementation ...

Roche’s Genentech unit signed a trio of deals this week to add new drug discovery platforms to its repertoire. The three drug discovery deals are with Convelo Therapeutics in neurological ...

drinate Dramamine OTC 50mg tabs, chew tabs Adults: Motion sickness: ≥12yrs: 50–100mg every 4–6hrs, start ½–1hr before travel; max 400mg/day. Children: <2yrs: Not recommended. Motion ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...